FLAG Therapeutics' Unattributed Round

FLAG Therapeutics raised a round of funding on March 15, 2016.

FLAG Therapeutics is an early-stage oncology company focused on the development of therapies based on two investigational product platforms--the Anti-angiogenic/Anti-tubulin (AA/AT) platform and Folat…

Articles about FLAG Therapeutics' Unattributed Round: